Ginirex Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-12-2024
- Paid Up Capital ₹ 1.00 M
as on 24-12-2024
- Company Age 4 Year, 7 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.50 Cr
as on 24-12-2024
- Revenue 34.83%
(FY 2023)
- Profit 107.75%
(FY 2023)
- Ebitda 92.38%
(FY 2023)
- Net Worth 66.76%
(FY 2023)
- Total Assets 61.39%
(FY 2023)
About Ginirex
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.50 Cr.
Rakesh Sharma, Deepshikha, and Shev Sharma serve as directors at the Company.
- CIN/LLPIN
U74999UP2021PTC140565
- Company No.
140565
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ginirex?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Sharma  | Managing Director | 19-Jan-2021 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Deepshikha | Director | 19-Jan-2021 | Current |
| Shev Sharma | Director | 19-Jan-2021 | Current |
Financial Performance of Ginirex.
Ginirex Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 34.83% increase. The company also saw a substantial improvement in profitability, with a 107.75% increase in profit. The company's net worth Soared by an impressive increase of 66.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ginirex?
Unlock access to Ginirex's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
₹35.00 M
₹0
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 3.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2024 | Yes Bank Limited | ₹1.00 Cr | Open |
| 24 Feb 2023 | Yes Bank Limited | ₹2.50 Cr | Open |
How Many Employees Work at Ginirex?
Unlock and access historical data on people associated with Ginirex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ginirex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ginirex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.